BioCentury
ARTICLE | Finance

Watchful waiting

How a single data event completely remade cancer play Celator's investor base

May 30, 2016 7:00 AM UTC

New SEC ownership filings reveal how a single data event completely revamped the shareholder base of Celator Pharmaceuticals Inc. (NASDAQ:CPXX). Overnight, the company's sub-$100 million valuation jumped to $308.8 million and the retail crowd that dominated its investor base was replaced by institutions.

The lesson for microcaps is institutions are paying attention, and an illiquid stock can become very fluid if data demand ownership...